Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.17
+0.11 (1.82%)
May 26, 2026, 1:55 PM EDT - Market open
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 76 employees as of December 31, 2025. The number of employees increased by 5 or 7.04% compared to the previous year.
Employees
76
Change (1Y)
5
Growth (1Y)
7.04%
Revenue / Employee
$488,961
Profits / Employee
-$234,553
Market Cap
105.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 5 | 7.04% |
| Dec 31, 2024 | 71 | -29 | -29.00% |
| Dec 31, 2023 | 100 | 78 | 354.55% |
| Dec 31, 2022 | 22 | -16 | -42.11% |
| Dec 31, 2021 | 38 | 9 | 31.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 124 |
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| enGene Therapeutics | 82 |
| Rani Therapeutics Holdings | 71 |
| PepGen | 56 |
| Vivani Medical | 42 |
| Biomea Fusion | 41 |
VRCA News
- 8 hours ago - Verrica Pharmaceuticals assumed with a Buy at H.C. Wainwright - TheFly
- 7 days ago - Verrica Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 13 days ago - Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 13 days ago - Verrica Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
- 13 days ago - Verrica Pharmaceuticals reports Q1 adjusted EPS (41c), consensus (59c) - TheFly
- 13 days ago - Verrica Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Verrica Pharmaceuticals Earnings release: Q1 2026 - Filings
- 13 days ago - Verrica Pharmaceuticals Quarterly report: Q1 2026 - Filings